Weicheng Pharmaceuticals

Suzhou, China · Founded 2025 · Privately Held (backing)

Developer of a proprietary extrahepatic drug delivery platform designed to advance targeted small nucleic acid therapies beyond hepatic tissues. Weicheng Pharmaceuticals is based in Suzhou, China and was founded in 2025. It has raised $64 million.

Last price · $/share
—
Implied valuation
—
Total raised
$64.0M
Last round
—
How much has Weicheng Pharmaceuticals raised?
$64.0Macross 0 recorded rounds

Weicheng Pharmaceuticals investors

4 investors are on record for Weicheng Pharmaceuticals, including Qiming Venture Partners, Highlight Capital, Apricot Capital (Shanghai) and TF Capital.

For fundraisers
Raising for a company like Weicheng Pharmaceuticals?

4 investors have backed Weicheng Pharmaceuticals.

See all 4 investors →

Frequently asked about Weicheng Pharmaceuticals

How much has Weicheng Pharmaceuticals raised?
Weicheng Pharmaceuticals has raised $64.0M in total across 0 recorded funding rounds.